| Oct 28 |
BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure
|
| Oct 9 |
BioCardia Inc (BCDA) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
|
| Sep 18 |
BioCardia regains compliance with Nasdaq Capital Market
|
| Sep 18 |
BioCardia Regains Full Compliance with Nasdaq Listing Requirements
|
| Sep 15 |
Wall Street Breakfast: The Week Ahead
|
| Sep 9 |
BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
|
| Sep 4 |
Peering Into BioCardia's Recent Short Interest
|
| Aug 30 |
BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
|
| Aug 30 |
Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
|
| Aug 29 |
Dow Jumps Over 100 Points; Nvidia Earnings Top Views
|
